Information Provided By:
Fly News Breaks for November 11, 2019
ACRX
Nov 11, 2019 | 06:25 EDT
Credit Suisse analyst Evan Seigerman downgraded AcelRx to Neutral from Outperform with a price target of $2, down from $7.
News For ACRX From the Last 2 Days
There are no results for your query ACRX